MedTrace Logo

Comparison of Comparison of Ropivacaine and Liposomal Bupivacaine for Total Knee Arthroplasty

NCT02616367 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2019-05-01

No results posted yet for this study

Summary

This is a randomized prospective outcomes study comparing two groups of patients. One group will receive liposomal bupivacaine for a periarticular injection. The other will receive ropivacaine for periarticular injection for pain relief after Total Knee Arthroplasty. the primary objective of this study is to determine if liposomal bupivacaine provides superior pain control (decreased maximal pain scores within the first 72 hours post surgery) when compared to ropivacaine when injected in a periarticular injection.

Conditions

  • Arthroplasty
  • Replacement
  • Knee

Interventions

DRUG

liposomal bupivacaine Periarticular injection

Liposomal bupivacaine used for a periarticular injection in the knee

DRUG

Ropivacaine Periarticular Injection

Periarticular Injection for the knee with ropivacaine

Sponsors & Collaborators

Principal Investigators

  • Roberto D Blanco · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2017-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02616367 on ClinicalTrials.gov